Back to DE D. E. Shaw & Co., Inc.

RAPPRAPP
3 quarters

Position history for DED. E. Shaw & Co., Inc.'s holdings in RAPPORT THERAPEUTICS INC

D. E. Shaw & Co., Inc. holds 214,831 shares of RAPP (RAPPORT THERAPEUTICS INC), worth $9M as of 2026-Q2. The position was increased (+22.4% shares). RAPP represents 0.0% of D. E. Shaw & Co., Inc.'s portfolio.

Current Value

$9M

Current Shares

214,831

Total Value Change

+$1.4M

Total Shares Change

-32,484

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
214,831
+22.4%
$9M0.0%$41.67
33
2026-Q1
Decreased
175,449
-29.1%
$5.5M0.0%$27.85
0
2025-Q4
New
247,315
-
$7.5M0.0%$30.64
38

Other major holders of RAPP: FMR LLC, Capital International Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used